Is there a place for nuclear medicine in the radioembolization of liver tumors?

Autor: Garin, É., Palard, X.

Publikováno v: In Medecine Nucleaire February 2017 41(1):21-26

TEP/TDM et cancer pulmonaire : indications et perspectives

Autor: Quéré, G., Abgral, R., Palard, X., Descourt, R., Noel Savina, E., Querellou, S., Le Fur, E., Salaün, P.Y.

Publikováno v: In Medecine Nucleaire August 2013 37(8):313-319

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres

Autor: Bouvry, C., Palard, X., Edeline, J., Ardisson, V., Loyer, P., Garin, E., Lepareur, N.

Publikováno v: BioMed Research International.

Liver malignancies, either primary tumours (mainly hepatocellular carcinoma and cholangiocarcinoma) or secondary hepatic metastases, are a major cause of death, with an increasing incidence. Among them, hepatocellular carcinoma (HCC) presents with a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=hindawi_publ::b5be12c3953563c0a3acd43afc2c31f5

Y a-t-il une place pour la médecine nucléaire dans la radioembolisation des tumeurs hépatiques ? [Is there a place for nuclear medicine in the radioembolization of liver tumors?]

Autor: Garin, E., Palard, X.

Publikováno v: Médecine Nucléaire
Médecine Nucléaire, Elsevier/Masson, 2017, 41 (1), pp.21-26. ⟨10.1016/j.mednuc.2017.02.005⟩
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique, 2017, 41 (1), pp.21-26. ⟨10.1016/j.mednuc.2017.02.005⟩

International audience; This is purposely an ultraprovocative title for the broad nuclear medicine community (including radiophysics and radiopharmacy) which leads us to ask questions about how we should correctly use 90Yttrium (MSY90) microspheres i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e0b0d35591f09580f7f72e49086013ae
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01508428